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Abstract
The Study of Cardiovascular Risk in Adolescents (ERICA) is a pioneer-
ing study that aimed to assess the prevalence of cardiovascular risk factors, 
including metabolic syndrome components in Brazilian adolescents. This 
study aims to describe the methodological aspects related to blood collection 
as well as to report pertaining results of the preparation, transport, storage, 
and exams in ERICA. Exams in ERICA were performed in a single labora-
tory and blood samples were collected in schools in a standardized manner. 
Logistics involved air transportation of samples to the reference laboratory 
with controlled temperature since sample collection. The serum was stored in 
local biorepositories in four centers to be used in future analyses. During the 
study, 284,247 exams were performed and rate of participation in exams was 
56.2%, thus involving 40,732 adolescents. From the total, 92.6% of the sam-
ples reached the reference laboratory maintaining the temperature between 
0-10°C. No clinical significant changes in results due to temperature changes 
were identified. External quality control recorded satisfactory results in 98.7% 
of the evaluations. Four biorepositories with samples of 7,785 adolescents were 
created. Thus, we can consider that the logistics adopted in ERICA was fair-
ly successful and description of this as well as the difficulties experienced in 
Brazil can inform and facilitate the planning of future studies, especially in 
developing countries.
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Introduction
Cardiovascular diseases (CVD) are responsible for 30% of deaths worldwide. The prevention and 
control of the major risk factors for CVD would theoretically reduce world mortality related to these 
diseases by half 1. In Brazil, CVD is the main cause of death and the major contributor to hospitaliza-
tion costs 2. Complex interactions between behavioral and biological (physiological, biochemical, 
and inflammatory) risk factors during childhood and especially in adolescence are important in the 
pathogenesis of atherosclerotic disease, the main CVD in adults 3.
Collection of biological material and biomarkers are important when assessing metabolic disor-
ders in epidemiological studies. A standardized collection of biologic samples poses challenges that 
include complex storage and transport logistics of biological material in multicenter epidemiological 
studies. Processes and handling in the pre-analytical phase, for example, may be responsible for 32% 
to 75% of the total variation of results in a laboratory test 4. In developing countries, conducting this 
type of study is even more challenging, due to difficulties in importing equipment and laboratory 
supplies, airway infrastructure issues, and inadequate number of transport routes, all of which make 
consistent information on biomarkers associated with CVD scarce in these populations.
In Brazil, in addition to the already mentioned difficulties, the continental extension of the 
country, regional differences, and logistical issues may add even more barriers to biomarker studies. 
Therefore, the Study of Cardiovascular Risk in Adolescents (ERICA; Estudo de Riscos de Cardiovasculares 
em Adolescentes in Portuguese) was set up to overcome these barriers. Its objectives were to estimate 
the prevalence of diabetes, hypertension, and metabolic syndrome, as well as other cardiovascular 
risk factors in adolescents aged from 12 to 17 years, living in Brazilian cities with more than 100,000 
inhabitants. Therefore, the objective of this study was to describe the methodological aspects related 
to planning and logistics of blood collection, as well as to report the pertaining results of the collec-
tion, transport, and storage of blood samples, and exams in ERICA.
Methods
ERICA’s sample design and data collection
ERICA is a national school-based cross-sectional study. A total of 1,247 (925 with blood collect) 
schools in 124 municipalities (45.4% of the possible municipalities) were selected. Data collection was 
performed between February 2013 and November 2014. The target population was divided into 32 
geographic strata: 27 state capitals and five more strata representing other municipalities with more 
than 100,000 inhabitants in each one of the macro regions of the country.
Schools were selected according to proportional probability for size, which was defined by the 
ratio of the number of eligible students in the school and the distance between the school and the 
state capital. Issues such as school location (urban or rural area) and administration (public or private) 
were also considered. This strategy allowed to center the sample in the vicinity of the capital, which 
reduced costs and facilitated the logistics of the study, especially concerning blood collection and 
adequacy of pre-analytical procedures.
In the second sample stage, three classes in each school were selected, considering combinations 
of the class period (morning or afternoon) and eligible grades (7th, 8th, 9th grades from elementary 
school and 1st, 2nd, and 3rd grades from high school). All students of randomly selected classes were 
invited to participate in ERICA, but only students of the morning classes participated in fasting blood 
collection and only adolescents aged between 12 and 17 years were eligible. Details of ERICA’s study 
design and sampling are available in other studies 5,6.
In summary, the first selected schools were contacted and invited to participate in the study. The 
students attending the randomly selected classes received information regarding the study. If they 
agreed to participate, they were registered on the ERICA online system and had their visits scheduled. 
The data collection in each class was held over two nonconsecutive days; on the first day, a question-
naire was applied using an electronic data collector (Personal Digital Assistant – PDA), anthropomet-
ric (weight, height, waist and arm circumference) and blood pressure measurements were taken, and 
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a 24-hour dietary recall was conducted. On the second day, a fasting blood sample was collected; as 
described below. Finally, two weeks after data collection, a member of the research team returned 
to the schools to deliver the results and conduct a second 24-hour dietary recall in a sub-sample of 
students. All adolescents who agreed to participate in the study and their parents or legal guardians 
signed the informed consent forms. ERICA was approved by the local Ethics Research Committee in 
each of the 27 Federation Units.
Blood collection and logistics: pre-analytical, quality indicators, and analytical care
ERICA’s research protocol was standardized across all 27 centers. For this purpose, it used a single 
laboratory, in which all biochemical analyses of the study were conducted. The reference laboratory, 
located in the city of Cascavel (Paraná State), included a network of 60 partner laboratories distrib-
uted by ERICA’s centers.
In addition to providing the infrastructure that contributed to the completion of the study, the 
reference laboratory was certified by the National Program of Quality Control (PNCQ; https://
www.pncq.org.br) connected to the Brazilian Society of Clinical Analysis, and by the Program 
of Accreditation of Clinical Laboratories (PALC; http://www.sbpc.org.br) of the Brazilian Soci-
ety of Clinical Pathology and Program of Laboratory Indicators (ControlLAB; http://www.control 
lab.com.br), which has a joint collaboration with the Brazilian Society of Clinical Pathology and 
Laboratory Medicine.
The reference laboratory identified one or more local partner laboratories in each of the 27 
centers to perform the collections of blood samples at schools. All laboratories followed exactly the 
same protocol throughout the study, from scheduling the blood collection to transportation to the 
central unit. Each laboratory was informed, via the reference laboratory, about the date, time, and 
location of the school in which to conduct the blood collection. The charges involving blood collec-
tion, transportation, and exams were agreed with the central laboratory as required at baseline by 
ERICA’s coordination.
Around ten days before the blood collection at schools, the central laboratory received a spread-
sheet generated by ERICA’s web system containing the name and numeric code of students in each 
enrolled class. This information was used to produce the tube labels with bar codes to allow the link-
age of the results of exams with participants’ information in the ERICA dataset. Every local laboratory 
obtained an identical kit for blood collection for each participant from the reference laboratory. The 
kit was composed of the following materials: four labels with bar code for identification of tubes; a 
zip bag for sending the samples separately for each participant; a tube with gel for measurements of 
total cholesterol, HDL cholesterol, triglycerides, and insulin; a fluoridated tube for measurement of 
glucose and a transport tube for the transfer of aliquot of plasma fluoride; a tube with ethylenediami-
netetraacetic acid (EDTA) for measuring glycated hemoglobin (HbA1c); a Pasteur’s pipette for aliquot 
of plasma fluoride; a needle for vacuum collection; and a swab of alcohol for antisepsis of the site of 
collection and occlusive dressing.
Figure 1 shows the logistics of the data collection in ERICA and the details of the blood collection 
for biochemical analyses. Blood samples were drawn after at least 12 hours of fasting. To confirm 
the compliance, a pre-examination questionnaire including questions about time of last food intake, 
bedtime and wake-up time on the day before the data collection, if any food or liquid was ingested, 
the use of medication on the day before blood collection (water and medications were allowed) was 
completed by each participant. For those who did not comply with the 12-hour fasting, a new attempt 
to collect the blood sample was scheduled appropriately. Additionally, in some specific cases, a direct 
collection at the local laboratory was offered.
All students were informed about the procedures before the blood samples were drawn and were 
free to withdraw at any point. First, correct identification was verified with the adolescent. Collection 
was performed using a vacuum needle for multiple collections, after asepsis of the collection site with 
alcohol, and a garroting time of less than one minute. After finishing the blood collection, all students 
received a snack. Industrialized foods were chosen mainly due to the durability of the products, which 
could be stored for approximately 90 days. The distribution to all Brazil regions was performed by a 
single company.
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Figure 1
Summary of blood collection, laboratory logistics, and analysis in Study of Cardiovascular Risk in Adolescents (ERICA). Brazil, 2013/2014.
All students provided four tubes, except in the four centers (Rio de Janeiro, Rio Grande do Sul, 
Federal District, and Ceará). In these centers, two additional gel tubes (4mL blood per tube) were col-
lected and stored for future analyses.
After homogenization, the tubes were stored in thermal boxes (0-10°C) before transportation 
to the local partner and, subsequently, to the reference laboratory. All blood samples were prepared 
according to a standardized protocol at each local laboratory before transportation to the reference 
laboratory: gel tubes were centrifuged for 10 minutes at 3,000rpm and then cooled; the primary 
fluoride tube underwent the same procedure before the plasma was separated and transferred to the 
transport tube; EDTA tubes were directly refrigerated to maintain the temperature below 10°C. All 
samples with pre-analytical problems (e.g. hemolysis) were destroyed at the local laboratory. Samples 
were packed in bags and then in thermal boxes with dry ice and transported to the reference labora-
tory by air.
The temperature was checked at three control points: at arrival at the local laboratory site, before 
transport and finally at the reference laboratory. The samples were kept between 0°C and 10°C 
during the entire air routes; samples outside this temperature range were identified and evalu-
ated for the occurrence of clotted, hemolytic, or lipemic samples. Results from samples outside the 
temperature range were compared with the others in crude analysis (mean and 95% confidence 
intervals). The acceptable analytic error by exam was established considering the biological and 
laboratory variations 7.
Analyses, methods, and equipment used for dosage, mean coefficient of variation, and cut-off 
points for each exam are presented in Table 1. Care taken by the reference laboratory in the review 
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process included a semi-annual preventive maintenance of equipment to ensure proper performance. 
All batches were validated when changed, considering the historical value for each exam.
Quantitative internal quality control was evaluated by the coefficient of variation for each analyte 
according to standard procedures (Clinical Laboratory Improvement Amendments – CLIA; https://
www.cms.gov/clia) and rules of Westgard et al. 8. Also, external controls by ControlLAB and PNCQ 
programs were periodically conducted for each of the analytes measured in ERICA. Exams with 
abnormal results were reassessed and results from the two tests compared and reported to the ERICA 
coordination team. Exams with discrepant values among the analyses were excluded.
Following analyses at the central reference laboratory, all results were sent to the ERICA central 
coordination center and entered into the ERICA database. All results were thereafter communicated 
in writing with the participants using a standardized data form. The need for any referrals to a local 
health service due to the presence of risk factors for CVD (e.g. dyslipidemia, hyperglycemia, or high 
HbA1c) was indicated in this form 5. If urgent, for example in case of a suspected new diagnosis of 
diabetes, the ERICA central coordination immediately contacted the local coordinator, who was 
responsible for contacting the adolescents.
Biorepository
For adolescents living in the states of Rio de Janeiro, Rio Grande do Sul, Ceará, and Federal Dis-
trict, the serum was stored in local biorepositories to be used in future analyses. All centers with 
biorepositories had -80°C ultra-freezers for sample conservation, adequate laboratory structure, 
and trained professionals to perform preparation, separation, identification, and organization of the 
stored samples.
The two tubes with gel underwent the same standardization already described for other analyses. 
However, instead of being transported from schools to the local laboratory, they were sent directly 
to the four research centers. At arrival, samples were centrifuged (10 minutes at 3,000rpm) and the 
serum was aliquoted into cryotubes pre-identified by bar codes. Thereafter, the samples were frac-
tionated according to the volume of blood, ranging from one to eight cryotubes containing 0.5mL of 
Table 1
Laboratory analyses performed in Study of Cardiovascular Risk in Adolescents (ERICA). Brazil, 2013/2014.
Exam Unit Method * Equipment Coefficient of 
variation (%)
Sample (n) ** Cut-off points
Desirable Borderline High
Glucose mg/dL Hexoquinase method ADVIA 2400 – 
Siemens
1.54 40,555 70-99 100-125.9 ≥ 126 18
Insulin mU/L Chemiluminescence Modular 
Analytics – 
Roche
3.58 40,576 < 15 15-20 ≥ 20 19
Glycated hemoglobin % Ion exchange 
chromatography
G7 – Tosoh 1.55 40,671 < 5.7 - ≥ 5.7 18
Triglycerides mg/dL Enzymatic kinetics ADVIA 2400 – 
Siemens
1.64 40,614 < 100 100-129 ≥ 130 20
Cholesterol mg/dL Enzymatic kinetics ADVIA 2400 – 
Siemens
1.65 40,617 < 150 150-169 ≥ 170 20
LDL-c mg/dL Friedewald equation - - 40,597 < 100 100-129 ≥ 130 20
HDL-c mg/dL Enzymatic colorimetric 
assay
ADVIA 2400 – 
Siemens
2.34 40,617 ≥ 45 20 - -
HDL-c: high density cholesterol; LDL-c: low density cholesterol. 
* Brazilian Society of Pathology; 
** Eligible adolescents (12-17 years old).
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each serum. All samples collected at schools were delivered to the research center within two hours 
and procedures for storage did not exceed four hours. The samples were stored in cryoboxes and 
organized by school. The position of each sample (row and column in cryoboxes) was inserted into an 
electronic spreadsheet to facilitate future localization.
Results
In total, 284,247 exams were performed by the reference laboratory throughout the study, including 
40,732 adolescents (12-17 years old). Less than 1% (n = 273) of the participants had some missing 
result. The main reasons for missing samples were insufficient amount of blood (61.2%), clotted, 
hemolytic, or lipemic samples (15%), and samples damaged during transport (14.6%).
The percentage of blood collection coverage in each center took into consideration for the cal-
culation the total number of eligible adolescents enrolled in ERICA and the final number of students 
who participated in the blood collection. Overall, 56.2% ERICA participants also had a blood sample 
collected, varying from 47.9% in Mato Grosso do Sul to 69.2% in Mato Grosso. In centers with biore-
positories, the coverage varied from 48.2% in Rio de Janeiro to 60.6% in Rio Grande do Sul.
The logistics adopted in ERICA allowed 92.6% of the blood samples to reach the reference labora-
tory with the appropriate temperature range (0-10°C). In 17 of the 27 centers, there was no record 
of samples with temperatures over 10°C. The highest proportions samples with temperatures above 
10°C were recorded in the North region, in the states of Amazonas (43.9%) and Pará (21.6%), and in the 
Northeast region, in Paraíba (19.2%) and Piauí (16.8%). Figure 2 shows box-plots for the temperature 
recorded in each of the centers. The median temperature ranged from 3.0°C in the Federal District to 
8.0°C in Amazonas. The mean blood temperature in ERICA was 6.2°C (±3.3) and despite changes in 
temperature during transportation, no clinically relevant differences were observed when data from 
the five states with the greatest percentage of samples with abnormal temperature were analyzed 
(Table 2).
Figure 3 shows the geographic distribution of all cities where blood collection was performed. 
Considering only one transport between each city enrolled in blood collection and the reference labo-
ratory, around 190,000km were covered. The distance of blood transportation varied from ≈ 350km 
from Londrina (state of Paraná) to ≈ 6,500km from Macapá (state of Amapá).
Regarding internal laboratory quality control, during the study period, the reference laboratory 
did not register coefficient of variation values for any of the analytes higher than the threshold value 
recommended by CLIA, which is below 5% for all analytes included in ERICA (Table 1). The external 
quality controls recorded satisfactory results in most instances (98.7%) and unsatisfactory results in 
only one (total cholesterol in August 2014).
Finally, four biorepositories were created with serum samples of 7,785 adolescents. In the cen-
ters of Rio de Janeiro, Rio Grande do Sul, Federal District, and Ceará: 7,301 (most of the cryotubes 
with 1mL), 12,719, 7,242, and 9,485 cryotubes with at least 0,5mL were stored, respectively. The 
main problem detected was hemolytic samples, which occurred in 11.4% of samples stored in Rio de 
Janeiro, the largest biorepository in ERICA. In this phase, all the collected samples were stored and 
information about problems as hemolysis will be considered before the future analysis.
Discussion
ERICA is a pioneer study that aims to evaluate lifestyle factors and cardiovascular biomarkers in ado-
lescents from 27 centers in Brazil, a country of continental dimensions. In spite of the complexity of 
the logistics used for data collection of the blood specimens, the execution of the study proved to be 
adequate. The quality control procedures showed satisfactory performance, for all tests. Additionally, 
a biorepository was created at four different centers and these samples can be used in future studies 
involving inflammatory, nutritional, and other novel cardiovascular disease biomarkers.
Considering a decline in the participation rates in epidemiological studies in the last decades 9, 
72.9% of the adolescents completed ERICA’s questionnaire (data not shown), and 56.2% of those 
BLOOD COLLECTION AND BIOCHEMICAL ANALYSIS IN ERICA 7
Cad. Saúde Pública 2017; 33(4):e00122816
Figure 2
Box-plots by center for temperature of blood samples upon arrival in ERICA’s reference laboratory. Brazil, 2013/2014.
ERICA: Study of Cardiovascular Risk in Adolescents.
eligible for blood samples agreed to participate in this part of the study. This participation rate is 
satisfactory, as compared to similar studies. In the Swedish part of the European Youth Heart Study, 
a school-based survey involving blood sampling obtained 49% (n = 1,137) of participation 10. In the 
HELENA study, a school-based study conducted in 10 European cities with adolescents aged from 12 
to 17 years, the overall participation rate was 67.1%. However, only one third of the adolescents were 
eligible for blood collection in that study and response rate was 68% (n = 1,076) 11. Despite the relative 
lower response rate, in ERICA, 70.9% (n = 72,508) of the adolescents were eligible for blood collection, 
as they studied during the morning, and 40,732 students participated in the blood sampling.
The collection of biological material and the logistics of ERICA represented a decisive step for 
the proper assessment and interpretation of results. The centralization of the biochemical analyses 
in a reference laboratory with strict quality control procedures, assisted by local partner laboratories 
that managed the field collection, ensured standardization of measures. The centralization of bio-
chemical analyses in a single laboratory has been adopted successfully by large-scale studies in Brazil 4 
and abroad 12. However, these studies involved a smaller number of participating centers compared 
to ERICA.
The strategy to centralize the laboratory tests aimed mainly to guarantee standardization of the 
methodology used, avoiding the inevitable variations between laboratories. With the care taken in 
ERICA, the laboratory results were more dependent on issues related to transportation and stor-
age than collection procedures and samples analyses. The guidelines for standardization of actions 
adhered to by local laboratory partner, to minimize pre-analytical issues, also contributed to the qual-
Cureau FV et al.8
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Table 2
Unadjusted analysis comparing results of biochemical exams according to temperature of blood sample in the five centers with higher percentages of 
samples with abnormal temperature (> 10°C) on arrival at the reference laboratory. Study of Cardiovascular Risk in Adolescents (ERICA), Brazil, 2013/2014.
Amazonas * Pará * Paraíba * Piauí * Goiás * Reference ** ATE 
(%)Mean 95%CI Mean 95%CI Mean 95%CI Mean 95%CI Mean 95%CI Mean 95%CI
Sample size 
(> 10°C)
1,625 
(689)
3,423 
(740)
1,376 
(264)
1,329 
(223)
2,348 
(231)
7,918 
(0)
Exams
Choles- 
terol (mg/
dL)
148.9 148.3-149.6 9.01
0-10°C 143.8 141.7-145.9 146.3 145.2-147.5 150.7 148.9-152.5 145.2 143.3-147.0 149.8 148.5-151.2
> 10°C 140.6 138.6-142.3 145.2 142.7-147.7 146.3 141.7-150.9 148.9 145.0-152.7 150.8 147.4-154.3
Δ% 2.23 0.75 2.92 2.48 0.66
HDL-c 
(mg/dL)
48.1 47.8-48.3 11.63
0-10°C 45.0 44.2-45.7 44.0 43.6-44.5 46.1 45.4-46.8 45.1 44.4-45.8 47.0 46.5-47.5
> 10°C 44.3 43.5-45.2 43.5 42.8-44.3 43.7 42.0-45.4 44.3 42.9-45.7 49.4 48.0-50.9
Δ% 1.55 1.14 5.21 1.77 4.85
Triglyce- 
rides (mg/
dL)
78.1 77.3-78.9 25.99
0-10°C 78.9 76.1-81.7 83.6 81.8-85.5 84.2 81.8-86.6 75.6 73.5-77.6 79.8 78.0-81.5
> 10°C 77.7 74.9-80.5 82.7 80.0-85.4 78.8 73.5-84.1 75.5 70.5-80.4 78.9 75.0-82.8
Δ% 1.52 1.08 6.41 0.13 1.13
Glucose 
(mg/dL)
85.9 85.7-86.1 6.96
0-10°C 84.8 84.1-85.6 84.2 83.9-84.5 86.7 86.1-87.4 86.2 85.6-86.8 84.3 84.0-84.7
> 10°C 85.3 84.7-86.0 85.0 84.4-85.6 80.7 79.3-82.1 86.2 85.3-87.2 83.7 82.9-84.6
Δ% 0.59 0.94 6.92 0.01 0.71
HbA1c (%) 5.36 5.35-5.37 3.00
0-10°C 5.46 5.43-5.50 5.43 5.42-5.44 5.41 5.38-5.44 5.38 5.34-5.41 5.38 5.36-5.40
> 10°C 5.40 5.37-5.42 5.43 5.40-5.46 5.41 5.36-5.45 5.41 5.36-5.46 5.40 5.36-5.44
Δ% 1.10 0.06 0.07 0.55 0.37
Insulin 
(mU/L)
9.79 9.64-9.94 32.90
0-10°C 8.45 8.04-8.86 8.88 8.60-9.16 7.48 7.11-7.84 7.78 7.51-8.06 7.55 7.27-7.83
> 10°C 8.81 8.16-9.46 8.23 7.59-8.88 7.79 6.99-8.58 6.68 6.13-7.23 6.42 5.96-6.88
Δ% 4.08 7.32 3.98 14.13 14.97
95%CI: 95% confidence interval; ATE: allowable total error; HbA1c: glycated hemoglobin; HDL-c: high density cholesterol; Δ%: difference in percentage 
between means by categories of temperature. 
* Centers with more than 10% of samples with altered temperatures of blood on arrival at the reference laboratory; highest blood temperature 
observed were: Amazonas, 17.3°C; Pará, 19.9°C; Paraíba, 17.0°C; Piauí, 21.6°C; Goiás, 18.9°C; 
** Mean value from the five centers, one from each Brazilian region, without registers of abnormal temperature: Rondônia, Rio Grande do Norte, 
Federal District, São Paulo and Paraná; In São Paulo, three samples with temperature > 10°C were excluded from this analyses.
ity of the biochemical data achieved in ERICA. Furthermore, the initiative of using a pre-examination 
interview to confirm fasting was important, as it minimized the occurrence of inadequate fasting, 
which may be a problem in the pre-analytical phase.
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In large-scale studies, logistics to transport biological material is the aspect that deserves espe-
cially careful planning, since most of the samples need to be kept in a controlled temperature to pre-
serve their integrity 13. In ERICA, all steps were carefully monitored to ensure that the samples were 
maintained between 0°C and 10°C during the entire process. However, possibly because of the large 
geographical extent and differences in structure of transport in Brazil, some samples were delivered 
to the reference laboratory outside this temperature range, although they were all duly identified and 
evaluated regarding their biological integrity before being analyzed.
The highest incidences of temperatures above the appropriate range were recorded in the North 
and Northeast regions, areas associated with higher temperatures and longer distances to the refer-
ence laboratory. For example, in the five centers with higher rates of sample with altered temperature 
(> 10°C), blood collection was done with ambient temperature around 30°C (mean = 29°C; range 
23-37°C). In the South region, most blood samples were collected during autumn and winter seasons 
Figure 3
Geographic distribution of Study of Cardiovascular Risk in Adolescents (ERICA) centers enrolled in blood collection.
Brazilian Federation Units: AC: Acre; AL: Alagoas; AM: Amazonas; AP: Amapá; BA: Bahia; CE: Ceará; DF: Federal District; ES: Espírito Santo; GO: Goiás;  
MA: Maranhão; MG: Minas Gerais; MS: Mato Grosso do Sul; MT: Mato Grosso; PA: Pará; PB: Paraíba; PE: Pernambuco; PI: Piauí; PR: Paraná;  
RJ: Rio de Janeiro; RN: Rio Grande do Norte; RO: Rondônia; RR: Roraima; RS: Rio Grande do Sul; SC: Santa Catarina; SE: Sergipe;  
SP: São Paulo; TO: Tocantins.
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(mean = 17°C; range 2-29°C). The majority of samples from this region were in the expected tempera-
ture. Furthermore, in the North and Northeast regions, airplane routes are limited and sometimes it 
was necessary to use other means of transportation for longer distances, which may have contributed 
to this result. However, a few hemolytic or lipemic samples were reported. In addition, prelimi-
nary comparative analyses did not show important variations in the test results due to temperature 
changes. It is also important to note that changes in temperature were rare. In the centers of the states 
of Goiás and Amazonas, temperature of samples changed during transport during 6 and 15 days, 
respectively, even though the data collection in these places extended more than 90 days.
Time is another important variable to be considered when evaluating sample stability before 
analysis. Kift et al. 14 examined the effect of storage conditions on sample stability and showed that 
triglycerides and HDL-c concentrations were increased after 16 hours in room temperature (≈ 20°C), 
but total cholesterol concentration remained stable. However, other authors reported that total 
cholesterol, triglycerides and HDL-c remain stable even after 24 hours up until 30°C, while glucose 
concentrations usually decreases progressively after six hours in room temperature 15,16. However, 
differences among studies, such as storage conditions, tube types, sample size and differences in the 
statistical techniques used to define significant change may affect results about stability. In ERICA, 
we compared the variation among samples in different categories of temperature with allowable total 
error for each analyte, and results suggest that observed differences were acceptable.
It is well known that there is a need to assess, monitor, and improve all pre-analytical and analyti-
cal steps of biomarker measurements in large studies 17, including identification of participants and 
biological material collected, storage, and transportation of samples 13. The ERICA study demonstrat-
ed that it is viable to carry out blood sampling, transportation, and analyses of cardio-vascular bio-
markers on study participants across the entire country. The partnership with local centers allowed 
proper data collection, transportation, and storage of materials within the pre-established time and 
under appropriate conditions. The participation rate was satisfactory and the percentage of missing 
samples was low. It was also possible to store biological material, which will allow future analyses 
focused on novel biomarkers associated with CVD development. Description of the logistics used 
during blood collection and the difficulties experienced in the ERICA study can inform and facilitate 
the planning of future studies, especially in developing countries, where investigators will probably 
face challenges similar to those found in Brazil.
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Resumo
O Estudo de Riscos de Cardiovasculares em 
Adolescentes (ERICA) é um estudo pioneiro que 
tem como objetivo avaliar a prevalência de fato-
res de risco cardiovascular, incluindo componentes 
da síndrome metabólica, entre adolescentes brasi-
leiros. Este artigo tem como objetivo descrever os 
aspectos metodológicos relacionados com a coleta 
de sangue, assim como informar os resultados da 
preparação, transporte, armazenamento e exames 
no ERICA. Os exames foram realizados em um 
único laboratório e as amostras de sangue foram 
coletadas de forma padronizada. A logística envol-
veu o transporte aéreo das amostra até o labora-
tório de referência, com a temperatura controlada 
desde a coleta do sangue. O soro foi armazenado 
em biorrepositores locais em quatro centros e se 
serão utilizados em análises futuras. Durante o 
estudo foram realizados 284.247 exames e a taxa 
de participação foi de 56,2%, representando 40.732 
adolescentes. Do total, 92,6% das amostras chega-
ram ao laboratório de referência mantendo a tem-
peratura entre 0-10°C. Não foram identificadas 
alterações clínicas significativas nos resultados 
devido a mudanças de temperatura. O controle 
de qualidade externo registrou resultados satis-
fatórios em 98,7% das avaliações. Foram criados 
quatro biorrepositores com amostras de 7.785 ado-
lescentes. Assim, podemos considerar que a logís-
tica adotada no ERICA foi bastante exitosa e sua 
descrição, tal como as dificuldades experimentadas 
no Brasil, podem informar e facilitar o planeja-
mento de futuros estudos, especialmente nos países 
em desenvolvimento. 
Coleta de Amostras Sanguíneas; Técnicas de 
Laboratório Clínico; Bancos de Espécimes 
Biológicos; Doenças Cardiovasculares; 
Adolescente
Resumen
El Estudio de Riesgos Cardiovasculares en 
Adolescentes (ERICA) es un estudio pionero que 
tiene como objetivo evaluar la prevalencia de fac-
tores de riesgo cardiovascular, incluyendo com-
ponentes del síndrome metabólico en adolescentes 
brasileños. Este estudio tiene como objetivo descri-
bir los aspectos metodológicos relacionados con la 
recolección de sangre, así como informar sobre los 
resultados de la preparación, transporte, almace-
namiento y exámenes en el ERICA. Los exámenes 
en ERICA se realizaron en un solo laboratorio y 
se recogieron muestras de sangre en las escuelas 
de manera estandarizada. La logística involucró 
el transporte aéreo de muestras al laboratorio de 
referencia con temperatura controlada desde la 
recolección de muestras. El suero fue almacenado 
en biorepositories locales en cuatro centros que se 
utilizarán en análises futuros. Durante el estudio 
se realizaron 284.247 exámenes y la tasa de par-
ticipación fue de 56,2%, lo que involucró a 40.732 
adolescentes. Del total, el 92,6% de las muestras al-
canzaron el laboratorio de referencia manteniendo 
la temperatura entre 0-10°C. No se identificaron 
cambios clínicos significativos en los resultados 
debido a cambios de temperatura. El control de 
calidad externo registró resultados satisfactorios 
en el 98,7% de las evaluaciones. Se crearon cuatro 
biorrepositores con muestras de 7.785 adolescentes. 
Así, podemos considerar que la logística adoptada 
en el ERICA fue bastante exitosa y su descripción 
así como las dificultades experimentadas en Bra-
sil pueden informar y facilitar la planificación 
de futuros estudios, especialmente en los países 
en desarrollo.
Recolección de Muestras de Sangre; Técnicas 
de Laboratorio Clínico; Bancos de Muestras 
Biológicas; Enfermedades Cardiovasculares; 
Adolescente
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